U.S. Markets open in 2 hrs, 8 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,433.71 | -17.24 | -0.16% |
| NASDAQ | 2,169.18 | -6.83 | -0.31% |
| S&P 500 | 1,105.65 | -0.59 | -0.05% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
| Day Low | 19.75 11:26 AM EST | |
|---|---|---|
| Day High | 20.51 09:30 AM EST |
|
| Range | 0.76 |
| Volume | 70,849 | |
|---|---|---|
| 30-Day Avg Vol | 129,000 |
|
| Difference | -45.08% |
| Market Cap | 562.73 M | |
|---|---|---|
| Mkt Cap Chg | 2.53 M |
| Shares Out | 28.15 M | |
|---|---|---|
| % Shrs Traded | 0.25% | |
| 1yr EPS Est | -1.659 |
| 52-Wk Low | 7.62 | |
|---|---|---|
| 52-Wk High | 24.605 |
|
| Range | 16.98 |
| Prev Close | 19.90 11/23/09 | |
|---|---|---|
| Today's Open | 20.01 | |
| Change | 0.55% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.16 M |
| Revenue (LFY) | 1.85 M | |
|---|---|---|
| Earnings (LFY) | -54.66 M | |
| Earnings (MRQ) | -6.95 M | |
| Next Earn Est | -0.528 | |
| Next Earnings | 11/25/2009 |
|
| EPS (TTM) | -2.24 | |
| 1yr EPS Growth | 27.87% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -12.00 | |
| PEG Ratio | -0.60 | |
| Return on Equity | -176.93 | |
| Beta | — |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more infoPharmasset uses its intellectual capital to take down the viruses that take down people's defenses. The company develops and plans to commercialize oral anti-viral drugs based on its nucleoside analog ... View Full Description

| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.528 12:00 AM EST | — — |
—
—
|
| Last Quarter | -0.345 6/30/09 | -0.25 6/30/09 |
0.095
Beat
|
| 2 Quarters Ago | -0.475 3/31/09 | -0.59 3/31/09 |
-0.115
Missed
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 10.50 M | 1.86 M |
| Gross Profit | 215,221.00 | 861,921.00 |
| Operating Income | -6.17 M | -54.43 M |
| Net Income | -6.95 M | -54.66 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.